Comments from participants in the recent Vaccine Forums include:

"Excellent. The best"
Dr Michael Balady, Acting Deputy Director, Medical Countermeasures, Office of Public Health Emergency Medical Countermeasures, Office of the Assistant Secretary for Preparedness & Response (ASPR), US Department of Health & Human Services

"Very well organised, covering hot topics and with ample opportunity for networking. A vibrant atmosphere"
Dr Hilde De Winter, Director, Clinical Development & Medical Affairs, Innogenetics

"Outstanding – up-to-date and ideal for networking"
Dr Olav Zilian, Finance Analyst – Biotech, Helvea

"I continue to find Phacilitate vaccine meetings to have strong speakers and agendas on a range of very timely topics"
Dr Ronald W. Ellis, Senior Vice President, R&D, AVANT Immunotherapeutics, Inc

"Excellent opportunity to connect with the vaccine industry’s key players and to network"
Dr Silke Fetzer, Head of Product Management, Cell Culture & Vaccine Operational Marketing, GE Healthcare

"Very good quality and mix of public/private sector speakers"
Peter Brazier, CEO, NewBiomed PIKA Pte Ltd

The Phacilitate Vaccine Forum Washington 2009 will be our 7th annual North American meeting for senior level industry and public sector figures driving the development of novel prophylactic and therapeutic vaccines.

The 3 day conference program will again feature a highly stimulating mixture of business, regulatory, investment and public policy topics, with the speaker panel featuring high level representatives of vaccine developers themselves, as well as key government agencies, NGOs and analysts.

We are very interested to receive your input into any additional topics you would like to see addressed during the 7th annual event and into the speakers you would like to hear from. Please complete a Shape your Event form or contact David McCall, Project Director, at david@phacilitate.co.uk with your thoughts and suggestions.

Networking

"Another well-organized conference, with excellent networking opportunities with top-level decision-makers"
Dr May de las Alas, Business Development Associate, Ichor Medical Systems, Inc

The Phacilitate Vaccine Forum Washington 2009 will run concurrently with Phacilitate’s 5th annual Cell & Gene Therapy Forum. Participants will be able to select the conference agenda of greatest current value to themselves and their organization, with all networking opportunities shared between the two events. Breakfast and lunch buffets, extended refreshment breaks and evening receptions will all take place in the shared exhibition area. A total of over 500 attendees participated in the combined event in 2008.

For more information on how your company can raise it’s profile with both sets of attendees all under one roof and in just three days, please click here.